Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

BACKGROUND: Immune checkpoint inhibitors (ICI) are an integral part of bladder cancer therapy, however, the relevance of ICI treatment for mixed and pure squamous cell carcinoma of the bladder remains poorly studied. Therefore, we analysed the expression of programmed death-ligand 1 (PD-L1) in uroth...

Descripción completa

Detalles Bibliográficos
Autores principales: Morsch, Ronja, Rose, Michael, Maurer, Angela, Cassataro, Maria Angela, Braunschweig, Till, Knüchel, Ruth, Vögeli, Thomas-Alexander, Ecke, Thorsten, Eckstein, Markus, Weyerer, Veronika, Esposito, Irene, Ackermann, Maximilian, Niegisch, Günter, Gaisa, Nadine T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079494/
https://www.ncbi.nlm.nih.gov/pubmed/32188412
http://dx.doi.org/10.1186/s12885-020-06727-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079494/
https://www.ncbi.nlm.nih.gov/pubmed/32188412
http://dx.doi.org/10.1186/s12885-020-06727-2

Ejemplares similares